Literature DB >> 33549870

Declining US Hepatocellular Carcinoma Rates, 2014-2017.

Meredith S Shiels1, Thomas R O'Brien2.   

Abstract

Liver cancer is a prominent cause of cancer death in the United States.1 Rates of hepatocellular carcinoma (HCC), the most common histologic subtype,2 increased for decades,3 until recent years when rates flattened,4 and then potentially declined. Previously, we reported that US HCC rates in 2016 were 4% lower than 20155; however, it was unclear from those data whether that finding reflected a true downward trend. Here, we examine HCC rates through 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33549870      PMCID: PMC8333245          DOI: 10.1016/j.cgh.2021.02.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  9 in total

1.  Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.

Authors:  Nicole E Rich; Adam C Yopp; Amit G Singal; Caitlin C Murphy
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-28       Impact factor: 11.382

2.  Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Authors:  Farhad Islami; Kimberly D Miller; Rebecca L Siegel; Stacey A Fedewa; Elizabeth M Ward; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-06-06       Impact factor: 508.702

3.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

4.  Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.

Authors:  John Ha; Melissa Yan; Maria Aguilar; Taft Bhuket; Michele M Tana; Benny Liu; Robert G Gish; Robert J Wong
Journal:  Cancer       Date:  2016-05-19       Impact factor: 6.860

5.  Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.

Authors:  Craig M Hales; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  NCHS Data Brief       Date:  2020-02

6.  Recent Decline in Hepatocellular Carcinoma Rates in the United States.

Authors:  Meredith S Shiels; Thomas R O'Brien
Journal:  Gastroenterology       Date:  2020-01-19       Impact factor: 22.682

7.  Patients with hepatocellular carcinoma from more rural and lower-income households have more advanced tumor stage at diagnosis and significantly higher mortality.

Authors:  Robert J Wong; Donghee Kim; Aijaz Ahmed; Ashwani K Singal
Journal:  Cancer       Date:  2020-10-26       Impact factor: 6.860

8.  Annual report to the nation on the status of cancer, part I: National cancer statistics.

Authors:  S Jane Henley; Elizabeth M Ward; Susan Scott; Jiemin Ma; Robert N Anderson; Albert U Firth; Cheryll C Thomas; Farhad Islami; Hannah K Weir; Denise Riedel Lewis; Recinda L Sherman; Manxia Wu; Vicki B Benard; Lisa C Richardson; Ahmedin Jemal; Kathleen Cronin; Betsy A Kohler
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

9.  Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.

Authors:  Robert J Wong; Sammy Saab; Peter Konyn; Vinay Sundaram; Mandana Khalili
Journal:  Am J Gastroenterol       Date:  2021-02-01       Impact factor: 12.045

  9 in total
  1 in total

1.  Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.

Authors:  Meera Sangaramoorthy; Juan Yang; Alice Guan; Mindy C DeRouen; Michele M Tana; Ma Somsouk; Caroline A Thompson; Joseph Gibbons; Chanda Ho; Janet N Chu; Iona Cheng; Scarlett Lin Gomez; Salma Shariff-Marco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-30       Impact factor: 4.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.